newsfilter
← Latest News
GlobeNewswire·

Vyant Bio Announces Robert T. Fremeau, Jr. Ph.D. as Chief Scientific Officer

Cherry Hill, N.J., Oct. 26, 2021 (GLOBE NEWSWIRE) -- Vyant Bio, Inc. ("Vyant Bio", "Company") (NASDAQ:VYNT), an emerging global drug discovery company identifying small and large molecule therapeutics to treat central nervous system (CNS) and oncology-